For the first time in 50 years, a phase 3 randomised, placebo-controlled trial found that an adjuvant therapy improved overall survival in kidney cancer patients.
Subscribe to our newsletter to get our newest articles instantly!
Foxiz has the most detailed features that will help bring more visitors and increase your site's overall.
Scientists have developed a novel blood test that uses lipids to identify children who are more susceptible to obesity-related problems,…
According to a study, a class of diabetes medications may be linked to a decreased risk of dementia and Parkinson's…
As society ages, the number of patients suffering from heart failure grows significantly. Fibrosis, or excessive growth of fibrotic tissue…
Long-term data from a landmark international trial show that about half of patients with metastatic melanoma treated with a combination…
Sign in to your account